Association Between Serum Caffeine Concentrations, Intermittent Hypoxia and Apnea in Preterm Infants: A Prospective...

Area of Science:

• Neonatal Medicine
• Pharmacology
• Clinical Research

Background:

• Caffeine citrate is the standard treatment for apnea of prematurity (AOP) and intermittent hypoxia (IH).
• Optimal dosing, monitoring, and indications for caffeine citrate in preterm infants require further clarification.
• Understanding serum caffeine concentration dynamics is essential for effective AOP and IH management.

Purpose of the Study:

• To assess longitudinal serum caffeine concentrations in preterm infants.
• To correlate caffeine levels with AOP and IH episode incidence.
• To determine if caffeine concentrations vary by gestational age postnatally.

Main Methods:

• A multicenter, prospective observational study of preterm infants (gestational age ≤30 weeks).
• Standard caffeine citrate loading and maintenance doses administered.
• Weekly serum caffeine level quantification and analysis stratified by gestational age groups (23-27 weeks vs. 28-30 weeks).

Main Results:

• 588 measurements from 104 preterm infants (median GA 28 weeks).
• No significant difference in serum caffeine by gestational age group (p > 0.05).
• Lower caffeine levels correlated with increased AOP (p=0.016) and IH episodes in weeks 3-5.

Conclusions:

• Serum caffeine concentrations do not significantly differ by gestational age in preterm infants.
• Lower caffeine levels are linked to higher incidences of AOP and IH.
• Maintaining adequate serum caffeine is critical for symptom control, though routine monitoring based on GA alone may not be necessary.